1. Dupixent is intended to treat patients with moderate to severe eczema.
2. Zejula can now be used as a maintenance treatment for patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer.
3. Bavencio is the first treatment for metastatic Merkel cell carcinoma, a rare form of skin cancer.
4. Ocrevus is intended to treat patients with severe forms of multiple sclerosis.
More articles on supply chain:
7 must-reads for supply chain leaders this week
America’s focus on technology — rather than medicine — is ‘eroding our national intellect,’ says pharma exec
Bill Ackman calls $4B Valeant investment ‘huge mistake’
